Robert L. FerrisStock and Other Ownership Interests: NovasentaConsulting or Advisory Role: Merck, Pfizer, EMD Serono, Numab, Macrogenics, Novasenta, Sanofi, Zymeworks, Bristol Myers Squibb, Aduro Biotech, Achilles Therapeutics, Bicara Therapeutics, Everest Clinical Research Corporation, F. Hoffmann-LaRoche Ltd, Genocea Biosciences Inc, Hookipa Pharma, Instil Bio, Kowa Research Institute Inc, Lifescience Dynamics Ltd, Mirati Therapeutics, OncoCyte, PPD Development LP, Rakuten Medical, Seattle Genetics, Vir BiologyResearch Funding: Bristol Myers Squibb, AstraZeneca/MedImmune, Merck, Tesaro, Novasenta Barbara BurtnessConsulting or Advisory Role: Merck, Debiopharm Group, CUE Biopharma, Maverick Therapeutics, Rakuten Medical, Nanobiotix, Macrogenics, ALX Oncology, IO Biotech, Ipsen, Genentech/Roche, Kura Oncology, Exelixis, Merck KGaA, PPD GlobalSpeakers' Bureau: Cancer Education Alliance, Oncology EducationResearch Funding: Merck (Inst), Exelixis (Inst), CUE Biopharma (Inst), Kura Oncology, Nektar, Eisai, Genentech, AstraZeneca, Rakuten MedicalTravel, Accommodations, Expenses: Merck, Debiopharm GroupNo other potential conflicts of interest were reported.